Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSystem1 Group Regulatory News (SYS1)

Share Price Information for System1 Group (SYS1)

Share Price is delayed by 15 minutes
Get Live Data
325.00    -8.00 (-2.40%)
Bid:
320.00
Ask:
330.00
Spread: 10.00 (3.125%)
Market Cap: £41.24m
SYS1 Live PriceLast checked at - London Stock Exchange

Intraday System1 Group Share Chart

Trading Update

16 Jul 2015 07:00

RNS Number : 1847T
BrainJuicer Group PLC
16 July 2015
 

 

 

 

 

Press Release 16 July 2015

 

BrainJuicer Group PLC

 ("BrainJuicer" and the "Company")

 

Pre close trading update

 

BrainJuicer (AIM: BJU), the international online market research agency, today releases the following half-year ("H1") trading update. The Company will announce its interim results for the 6 months to 30 June 2015 on 24 September 2015.

 

Overall, the Company achieved revenue growth of approximately 4% compared with the same period in 2014. The overall impact of exchange rate movements was not material. Sales of BrainJuicer's core quantitative products, approximately 90% of our business, increased by around 7%, with gross profit on these products increasing by 11%. This was partially offset by a decline in revenue from Juice Generation, as we transition these services to our new Brand Strategy initiative.

 

Our two main markets experienced contrasting fortunes during the half. The US delivered strong growth ahead of H1 2014, but in the UK sales were below the H1 2014 level. Elsewhere, Continental Europe grew strongly, and Brazil also made good progress.

 

Overheads grew faster than revenue during the half, as the business continued to invest for future growth. We recruited two senior managers to spearhead the Brand Strategy initiative, and average headcount was 10% higher than in the comparable period. H1 2015 also included some one-off costs, including costs relating to moving our HQ to larger offices in London, which occurred in June (this move has now been completed). Due in part to one off costs, including the above, first half profit before tax will be approximately 25% lower than that achieved in 2014.

 

 

 

 

 

 

The Company's financial position remains strong. At the end of June 2015, the Company had a cash balance of £5.3m (December 2014: £5.3m), after having returned £0.4m to shareholders during the half year by way of dividends.

 

The Company has enjoyed good growth in its core quantitative products in the first half, and it does not anticipate incurring further material one-off costs in the second half. The Company generates the majority of its profit in the second half, and whilst revenue visibility remains typically limited the Board believes the Company is in a position to meet profit expectations for the full year.

 

The Company can be found at www.brainjuicer.com

 

- Ends -

 

 

For further information, please contact:

 

BrainJuicer Group PLC

John Kearon, Chief Executive Officer Tel: +44 (0)20 7043 1000

James Geddes, Chief Financial Officer www.brainjuicer.com

 

Canaccord Genuity Limited

Simon Bridges / Henry Fitzgerald-O'Connor Tel: +44 (0)20 7523 8000

www.canaccordgenuity.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUVRARVKABAUR
Date   Source Headline
24th Mar 20101:22 pmRNSDirector/PDMR Shareholding
10th Mar 20103:11 pmRNSBlocklisting Interim Review
10th Mar 20103:05 pmRNS2009 Final Dividend
10th Mar 20107:38 amRNS2010 Interim Dividend
9th Mar 20107:00 amRNSFinal Results
1st Feb 20107:00 amRNSAlex Batchelor Appointed COO
19th Jan 20107:00 amRNSTrading Update
4th Jan 20102:10 pmRNSShare Dealings
22nd Sep 20097:00 amRNSInterim Dividend
22nd Sep 20097:00 amRNSInterim Results
1st Sep 20097:00 amRNSNotice of Results
8th Jul 200912:46 pmRNSShare Dealings
8th Jul 20097:00 amRNSTrading Statement
13th May 200910:20 amRNSResult of AGM
17th Apr 20097:00 amRNSNotice of AGM
16th Apr 20093:15 pmRNSFinal Dividend
2nd Apr 20097:00 amRNSTrading on Sharemark
19th Mar 20097:00 amRNSPreliminary Results
5th Feb 200910:35 amRNSBlocklisting Interim Review and TVR
19th Jan 20097:00 amRNSPre-Close Trading Statement
13th Jan 200910:41 amRNSDirector's Dealings
9th Jan 20092:18 pmRNSDirector's Dealings
9th Dec 20087:00 amRNSExercise of Share Options
25th Nov 20087:00 amRNSDirector/PDMR Shareholding
13th Nov 20087:00 amRNSChange of Adviser
8th Oct 20086:02 pmRNSChange of Adviser Name
5th Sep 20087:00 amRNSInterim Results
4th Aug 20081:08 pmRNSBlocklisting Interim Review
1st Jul 20087:00 amRNSPre-Close Trading Statement
16th Jun 20087:00 amRNSGlobal Expansion
21st May 20084:40 pmRNSResult of AGM
10th Mar 20087:01 amRNSFinal Results
29th Feb 20087:00 amRNSTotal Voting Rights
25th Feb 20087:01 amRNSBlock Listing
12th Feb 20087:00 amRNSNotice of Results
11th Feb 20087:01 amRNSGlobal strategy
15th Jan 20087:00 amRNSTrading update
28th Dec 20074:51 pmRNSDirectors Dealing error
28th Dec 200711:38 amRNSDirectors Dealings
30th Nov 20077:00 amRNSIssue of Equity & TVR
31st Oct 20077:01 amRNSTotal Voting Rights
12th Oct 20077:01 amRNSIssue of Equity
20th Sep 20077:02 amRNSIndustry Award Winner
14th Sep 20071:15 pmRNSDirector/PDMR Shareholding
13th Sep 20077:01 amRNSInterim Results
5th Sep 20075:44 pmRNSNon-Exec Chairman Appointment
5th Sep 20077:01 amRNSNon-Exec Chairman Appointment
4th Sep 20077:01 amRNSNotice of Results
15th Aug 20078:10 amRNSAIM 26 and NOMAD name change
11th Jun 20077:02 amRNSCreativity Test

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.